Shift in Chemistry Quality Control After a Reagent Lot Change
A 220-bed community hospital laboratory runs a chemistry analyzer with two levels of quality control material every 8 hours. On Monday a new lot of creatinine reagent is put into service after the supervisor's lot-to-lot comparison passes. On Tuesday night, the technologist sees QC results of +2.4 SD and +2.6 SD for levels 1 and 2, both on the same side of the mean. She repeats the controls; the second run falls within 2 SD, so she proceeds with patient testing. On Wednesday the level 2 control is +3.2 SD. She repeats it twice; the second repeat is +1.9 SD, so she reports the 46 creatinine results run during the shift. On Thursday, during a records review, the supervisor pulls the Levey-Jennings charts and the QC log and sees the pattern.
1. Identify the QC rule violations and the error in the technologist's response.
Read the worked answer
Rule violations:
- Tuesday: two consecutive control measurements (both levels) exceed the mean by more than 2 SD on the same side. This is a 2-2s violation, one of the Westgard multirule rejection criteria, and it signals systematic error. The run should have been rejected.
- Wednesday: a single control exceeds 3 SD. This is a 1-3s violation, also a rejection rule (most often random error, but in the context of a persistent positive shift it suggests a systematic problem that has worsened).
- Taken together, Tuesday plus Wednesday shows a shift: consecutive values on one side of the mean across days and levels, the classic pattern of calibration bias, a bad reagent lot, or a deteriorating component (lamp, probe, tubing, water quality).
The error in practice: the technologist treated QC as something to be repeated until acceptable, rather than a decision rule. Repeat-until-in-range is a well-recognized QC failure mode - repeating without investigating simply resamples from the same distribution and eventually yields a value inside the limits by chance. There was no documented investigation, no corrective action, and no supervisor notification before patient results were released, which means the results were reported while the system was demonstrably out of control.
2. What corrective action is required now, and how do you handle the patient results that were already reported?
Read the worked answer
Immediate containment. Stop reporting creatinine until control is re-established. Recalibrate with a fresh aliquot of calibrator, then re-verify with an independent QC material (not the same vial that was failing). Replace the new reagent lot with the prior lot if bias persists and the prior lot is still in control. Check the usual culprits systematically: reagent lot and storage/expiration, calibrator stability, probe and syringe integrity, lamp output, water quality, and any recent change to a shared reagent or diluent.
Patient look-back. The 46 results reported Wednesday (and any affected runs since the bias began) must be evaluated:
- Reassay retained or already-drawn specimens if available, and compare to the reported values.
- Run a delta check against each patient's prior creatinine; flag results that changed implausibly over the interval.
- Use the magnitude and direction of the bias measured on the QC material to estimate whether reported values could have altered clinical decisions (e.g., a creatinine reported falsely high in a patient with a stable eGFR, or falsely low in a patient being monitored for acute kidney injury).
- Notify the responsible clinicians, issue corrected reports where results were wrong, and document the notification, the affected accession numbers, and the corrective action.
Do not issue corrected reports until the magnitude of error is characterized; a blanket 'results may be inaccurate' notice is unhelpful and usually fails inspection.
3. What process changes prevent a recurrence, and what documentation is required?
Read the worked answer
Process changes:
- Formal training and annual competency assessment on Westgard multirule interpretation for all shifts, with worked examples of shifts, trends, 2-2s, 1-3s, R-4s, and 4-1s, and with explicit instruction that repeating controls without investigation is prohibited.
- A written procedure requiring documented corrective action and supervisor notification before any patient result is released from a rejected run.
- Pre-defined lot-to-lot verification acceptance criteria (e.g., acceptable bias limits, number of patient samples compared, statistical criteria) written down before the comparison is performed - the Monday 'pass' was judged without pre-specified criteria, which is how a biased lot can be accepted.
- Daily review of Levey-Jennings charts by a supervisor, not just by the bench technologist, and periodic audit of the QC log for repeat patterns.
Documentation required:
- The QC log showing each control value, the rule violated, the investigation performed, the corrective action, and the resolution.
- Reagent lot verification records, calibration records, and the training/competency records for each technologist involved (including those on nights and weekends).
- The patient look-back record: which specimens were repeated, which reports were corrected, who was notified, and when.
- Records must be retained per the laboratory's accreditation requirements (CLIA/CAP) and available for inspection; a QC program that cannot demonstrate documented investigation of out-of-control runs is a routinely cited deficiency.